MM+M Transform Insights: Patient Privacy and Real-World Data Models
How can life sciences brands leverage real-world data and AI-driven tools while safeguarding patient privacy?
The growing use of real-world data and AI-driven tools has...
The growing use of real-world data and AI-driven tools has...
With life science manufacturers’ interest in EHR-based solutions for HCP engagement growing, navigating recent market growth and companies’ claims about EHR network access...
HCPs marketers continue to embrace digital channels as they pursue “omnichannel” strategies, but social media is often a misunderstood – or overlooked – channel to engage and...
Life science manufacturers’ interest in EHR-based solutions for HCP engagement continues to grow. But with companies’ varying claims about EHR network access and reach,...
During my recent session at HLTH, I had the great opportunity to share a case study on how AI and real world data (RWD) increased medication affordability for patients by...
Real-World Data (RWD) has become an essential element of pharmaceutical marketing, but as an industry, we are far from utilizing its full potential. During my recent session...
Real-World Data (RWD) has become an integral, inseparable element of omnichannel marketing (OCM), which is an increasingly...
During the recent Digital Pharma Innovation Week, I had the great opportunity to lead a roundtable discussion with a group of stakeholders from across the pharma industry...
In the quest to improve patient outcomes, life sciences companies are increasing their focus on optimizing the patient...
With COVID-19 still impacting provider facetime for brand field teams, life sciences organizations need new ways to deliver information that supports HCP awareness. That’s...
Omnichannel marketing continues to be a hot topic among pharma brand teams, but too often I see our clients struggling to convert their tactics and strategies into a true...
OptimizeRx was recently a proud Global Sponsor of Pharma USA 2021, pharma’s first “virtual congress” to look beyond the pandemic to pharma’s future. For seven days, pharma...